DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Syros Pharmaceuticals Q4 EPS $(0.46) Beats $(0.47) Estimate, Sales $508K Miss $690K Estimate

Syros Pharmaceuticals (NASDAQ:SYRS) reported quarterly losses of $(0.46) per share which beat the analyst consensus estimate of $(0.47) by 2.13 percent. This is a 14.81 percent increase over losses of $(0.54) per share

Benzinga · 03/05/2020 12:37

Syros Pharmaceuticals (NASDAQ:SYRS) reported quarterly losses of $(0.46) per share which beat the analyst consensus estimate of $(0.47) by 2.13 percent. This is a 14.81 percent increase over losses of $(0.54) per share from the same period last year. The company reported quarterly sales of $508 thousand which missed the analyst consensus estimate of $690 thousand by 26.38 percent. This is a 43.11 percent decrease over sales of $893 thousand the same period last year.